SEC 13F Intelligence

Claret Asset Management Corp / CVS

Claret Asset Management Corp’s Cvs Health Corp Position

Does Claret Asset Management Corp own Cvs Health Corp (CVS)? Yes289.3K shares worth $21M (+2.48% of its 13F portfolio) as of Q1 2026, up from 287.9K shares the prior filed quarter.

Position Value
$21M
Q1 2026
Shares
289.3K
% of Portfolio
+2.48%
Quarters Held
29
currently held

Position History CVS

Reported value by quarter
Q4 ’18: $8MQ4 ’18Q1 ’19: $7MQ2 ’19: $7MQ3 ’19: $8MQ4 ’19: $10MQ4 ’19Q1 ’20: $8MQ2 ’20: $11MQ3 ’20: $12MQ4 ’20: $14MQ4 ’20Q1 ’21: $15MQ2 ’21: $17MQ4 ’21: $21MQ1 ’22: $21MQ1 ’22Q2 ’22: $20MQ3 ’22: $20MQ4 ’22: $20MQ1 ’23: $19MQ1 ’23Q2 ’23: $18MQ3 ’23: $20MQ4 ’23: $22MQ1 ’24: $22MQ1 ’24Q2 ’24: $16MQ3 ’24: $17MQ4 ’24: $14MQ1 ’25: $20MQ1 ’25Q2 ’25: $20MQ3 ’25: $22MQ4 ’25: $23MQ1 ’26: $21MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026289.3K$21M+2.48%
Q4 2025287.9K$23M+2.65%
Q3 2025292.4K$22M+2.63%
Q2 2025296.4K$20M+2.65%
Q1 2025298.0K$20M+2.91%
Q4 2024301.7K$14M+2.14%
Q3 2024273.2K$17M+2.81%
Q2 2024275.8K$16M+2.90%
Q1 2024279.3K$22M+3.74%
Q4 2023280.3K$22M+3.96%
Q3 2023279.5K$20M+3.83%
Q2 2023263.2K$18M+3.55%
Q1 2023258.3K$19M+3.79%
Q4 2022215.7K$20M+4.44%
Q3 2022214.4K$20M+4.85%
Q2 2022212.6K$20M+4.25%
Q1 2022211.0K$21M+4.11%
Q4 2021208.0K$21M+3.97%
Q2 2021208.4K$17M+2.85%
Q1 2021204.4K$15M+2.85%
Q4 2020206.9K$14M+2.79%
Q3 2020210.5K$12M+2.74%
Q2 2020176.9K$11M+2.72%
Q1 2020133.9K$8M+2.24%
Q4 2019131.0K$10M+1.87%
Q3 2019128.3K$8M+1.66%
Q2 2019123.9K$7M+1.40%
Q1 2019122.7K$7M+1.32%
Q4 2018120.4K$8M+1.75%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Claret Asset Management Corp’s full portfolio or all institutional holders of CVS.